Product Information
BACLOFEN 5 MG TABLET is a generic product labeled by Lannett Company Inc., priced at $0.0680 per EA under NDC 00527133301. Its NADAC has been published 206 times since Oct 26, 2022.
FDA first approved this application on Dec 20, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Lannett Company Inc.NDC
00527133301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BACLOFENApproval Type
Generic (ANDA)
FDA Application
ANDA077241FDA Approved
12/20/2005
TE Code
AB
On Market Since
9/22/2021
Pharmacological Classes
Price Statistics
The NADAC for BACLOFEN 5 MG TABLET has been published 206 times since Oct 26, 2022, and over the history we have for it it has declined 76.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0680 per EA |
|---|---|
| All-time high | $0.2993 (Dec 14, 2022) |
| All-time low | $0.0631 (Jul 22, 2026) |
| 52-week high | $0.1075 |
| 52-week low | $0.0631 |
| Median price | $0.1196 |
| Average price | $0.1396 |
| Largest weekly change | +41.7% (Jun 19, 2024) |
| Weeks tracked | 206 |
| Tracking since | Oct 26, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the baclofen market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lannett Company Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
baclofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
gamma-Aminobutyric Acid-ergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BACLOFEN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BACLOFEN 5 MG TABLET, manufactured by Lannett Company Inc., is $0.0680 per EA (NDC 00527133301), effective Sep 30, 2026.
How has the price of BACLOFEN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BACLOFEN 5 MG TABLET has declined 76.4%. It has been tracked across 206 weekly CMS publications since Oct 26, 2022.
What are the highest and lowest recorded NADAC prices for BACLOFEN 5 MG TABLET?
Since Oct 26, 2022, the NADAC for BACLOFEN 5 MG TABLET has ranged from a low of $0.0631 (Jul 22, 2026) to a high of $0.2993 (Dec 14, 2022), with a median of $0.1196 per EA.
Are there cheaper alternatives to BACLOFEN 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of BACLOFEN 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BACLOFEN 5 MG TABLET?
BACLOFEN 5 MG TABLET (NDC 00527133301) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.